Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dosimetry of Holmium-166-DOTMP in Multiple Myeloma
NCT00045136Phase 2Completed
- Sponsor
- Poniard Pharmaceuticals, Inc.
- Start
- Jan 2002
- Primary completion
- Jan 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Holmium-166-DOTMP in multiple myeloma (MM), sponsored by Poniard Pharmaceuticals, Inc.. Started Jan 2002; status: completed.
02
Drugs
Holmium-166-DOTMP
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00045136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00045136.